Skip to content

CDR

CVS ahead of Q4 earnings forecasts

CVS ahead of Q4 earnings forecasts

CVS Health posted stronger-than-expected fourth quarter earnings Wednesday but issued 2019 profit guidance that fell short of Wall Street forecasts linked to “significant additional deterioration” in its long-term care business.

Teva introduces a generic of Acanya

Teva introduces a generic of Acanya

Teva Pharmaceuticals announces the introduction and availability of clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5%. This product is AB rated and bioequivalent to Acanya (Clindamycin Phosphate and Benzoyl Peroxide) Gel. Teva Pharmaceuticals USA, Inc.

Walmart posts strong revenue growth for Q4

Walmart posts strong revenue growth for Q4

Walmart on Tuesday reported robust profit and revenue figures for the holiday quarter, citing strength across a range of product categories and a 43% surge in digital sales. Revenue was up 1.9% to $138.8 billion in the fiscal fourth quarter.